Bide Pharmatech Co

Bide Pharmatech Co EBITDA per Employee

The EBITDA per Employee of Bide Pharmatech Co (688073.SS) as of Oct 16, 2026 is 391,654.26 CNY. In the previous year, EBITDA per Employee was 291,921.23 CNY — a change of 34.16% (higher).

EBITDA per Employee

391,654.26CNY

YoY

34.16%

Last updated:

EBITDA per Employee of Bide Pharmatech Co is 2025 391,654.26 CNY. EBITDA per Employee of Bide Pharmatech Co was 2024 291,921.23 CNY. It decreases by 34.16% higher compared to the previous year.

The Bide Pharmatech Co EBITDA per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Employee
Date
EBITDA per Employee
Jan 1, 2019
17,926.26 CNY
Jan 1, 2020
160,287.89 CNY
Jan 1, 2021
218,214.26 CNY
Jan 1, 2022
292,241.69 CNY
Jan 1, 2023
239,186.90 CNY
Jan 1, 2024
291,921.23 CNY
Jan 1, 2025
391,654.26 CNY
The Bide Pharmatech Co EBITDA per Employee history
YEAREBITDA per EmployeeYoY
391,654.26CNY+34.16%
291,921.23CNY+22.05%
239,186.90CNY-18.15%
292,241.69CNY+33.92%
218,214.26CNY+36.14%
160,287.89CNY+794.15%
17,926.26CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bide Pharmatech Co Stock analysis

What does Bide Pharmatech Co do? Bide Pharmatech Co Ltd is a pharmaceutical company headquartered in Shanghai, China, operating within the Health Care sector. The company focuses on the research, development, design, production, and sales of drug molecular building blocks, which are essential components in pharmaceutical manufacturing. Its main products include pharmaceutical molecular building blocks and scientific reagents, utilized in various stages of drug development such as target discovery, compound screening, and synthesis optimization. Bide Pharmatech employs 617 full-time staff and completed its initial public offering (IPO) on October 11, 2022. The company serves markets across the Asia Pacific region, India, Europe, and the United States. Its website is https://www.bidepharmatech.com/. The firm's operations are centered on providing specialized chemical solutions for the pharmaceutical industry, supporting the development of new drugs and therapeutic compounds. Bide Pharmatech does not disclose specific details about its founding year, key executives, or acquisition history. Financial figures beyond the employee count and IPO date are not provided in the available information. The company operates as a publicly traded entity under the ticker symbol 688073.SS and ISIN CNE100005NV3. It maintains a presence in multiple global markets, emphasizing its role in the pharmaceutical supply chain as a supplier of critical molecular components. Bide Pharmatech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bide Pharmatech Co stock

EBITDA per Employee of Bide Pharmatech Co is 391,654.26 CNY in 2025.

EBITDA per Employee of Bide Pharmatech Co changed from 291,921.23 CNY to 391,654.26 CNY, representing a 34.16% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee Bide Pharmatech Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Bide Pharmatech Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Bide Pharmatech Co

All Key Metrics — Bide Pharmatech Co